Artemisinin‐based combination therapy for treating uncomplicated Plasmodium vivax malaria
D Sinclair, N Gogtay, F Brand… - Cochrane database of …, 2011 - cochranelibrary.com
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and resistance to the standard treatment (chloroquine) is now high in some …
South America, and resistance to the standard treatment (chloroquine) is now high in some …
[PDF][PDF] Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivaxmalaria
D Sinclair, N Gogtay, F Brand… - status and date: Edited …, 2011 - scholar.archive.org
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and resistance to the standard treatment (chloroquine) is now high in some …
South America, and resistance to the standard treatment (chloroquine) is now high in some …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
D Sinclair, N Gogtay, F Brand… - The Cochrane Database of …, 2011 - europepmc.org
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and resistance to the standard treatment (chloroquine) is now high in some …
South America, and resistance to the standard treatment (chloroquine) is now high in some …
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
D Sinclair, N Gogtay, F Brand… - … Cochrane database of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and resistance to the standard treatment (chloroquine) is now high in some …
South America, and resistance to the standard treatment (chloroquine) is now high in some …